Non-invasive egg retrieval protocols and methods
AssigneeButterfly Biosciences, Inc.
InventorsSam Najmabadi, Moses Cesario, Alexander Nadal, Steven T. Nakajima, José Luis Rivas, Ricardo Peraza
Life of this patent
Estimating the term…
Loading patent…
AssigneeButterfly Biosciences, Inc.
InventorsSam Najmabadi, Moses Cesario, Alexander Nadal, Steven T. Nakajima, José Luis Rivas, Ricardo Peraza
Estimating the term…
Methods for non-invasive retrieval of viable (i.e., able to be fertilized) oocytes from the uterus via a combination of unique ovarian stimulation and uterine lavage technology. These methods may eliminate the need for an invasive surgical procedure. Embodiments include the use of a novel hormonal protocol, including the use of injectable gonadotropins, to induce the release of immature oocytes from the ovaries of a patient. The immature oocytes mature as they transit the fallopian tubes such that mature, viable oocytes may be collected from the uterus via a uterine lavage procedure. Further embodiments include the use of a novel hormonal protocol, including the administration of Prostaglandins, Estradiol, and/or Progesterone Blockers, to accelerate transport of oocytes through the fallopian tubes. Further embodiments include kits for uterine lavage, compositions suitable for triggering and inducing superovulation, and compositions suitable for accelerating tubal transport of mature oocytes in a female patient.
A kit for uterine lavage, consisting of:
A kit for uterine lavage, comprising a uterine lavage catheter configured for insertion into a woman's uterus to remove mature oocytes from the uterus;
A composition suitable for triggering and inducing superovulation in a female patient over a period of 3 to 11 days to produce a plurality of mature oocytes in the women's uterus, wherein the composition includes a dosage amount of an injectable gonadotropin of between about 500 to 10000 IU's.
A composition suitable for accelerating tubal transport of mature oocytes in a female patient over a period of 1 to 6 days, comprising a progesterone receptor blocker at a dosage amount of between 100-2,000 mg, estradiol at a dosage amount of between 2-10 mg/day, and/or a prostaglandin at a dosage amount of between 20-1600 mg.
A method of inducing superovulation in a female patient to produce a plurality of mature oocytes in the uterus of the patient, the method comprising administering an injectable gonadotropin to produce a plurality of oocytes wherein the gonadotropin is administered daily for up to eleven days or until the dominant follicle is at or between 8-18 mm in diameter as confirmed by ultrasound imaging of the ovaries.
A method of retrieval of a plurality of mature oocytes from the uterus of a female patient, the method comprising administering an injectable gonadotropin to produce a plurality of oocytes wherein the gonadotropin is administered daily for up to eleven days or until the dominant follicle is at or between 8-18 mm in diameter as confirmed by ultrasound imaging of the ovaries, administering one or more agents to the female patient to accelerate tubal transport of the plurality of oocytes, and performing uterine lavage to remove the plurality of mature oocytes from the uterus of the patient.
Dependencies are inferred from the claim text.